8-K: Sabra Health Care REIT Reports Strong Q4 2024 Results and Introduces Optimistic 2025 Guidance

Sabra Health Care REIT announces positive Q4 2024 results, driven by strong operator performance and strategic portfolio management, while also introducing promising 2025 earnings guidance.

Summary

• Sabra Health Care REIT reported its Q4 2024 results, showcasing a net income of $0.19 per diluted common share.
• FFO was reported at $0.36, with Normalized FFO at $0.35 and AFFO at $0.36 per diluted common share.
• The company's skilled nursing/transitional care EBITDARM coverage stood at 2.09x, while senior housing-leased was at 1.36x.
• Behavioral health, specialty hospitals, and other facilities had an EBITDARM coverage of 3.66x.
• Same-store managed senior housing Cash NOI increased by 17.9% year-over-year.
• Sabra closed the acquisition of a managed senior housing community for $24.0 million with an initial expected cash yield of 8.6%.
• The company completed dispositions of nine skilled nursing facilities and one behavioral health facility for gross proceeds of $56.5 million with a cash yield of 8.5%.
• For the year ended December 31, 2024, Sabra utilized its ATM program to allow for the sale of up to 7.5 million shares at an initial weighted average price of $15.47 per share, net of commissions.
• As of December 31, 2024, 1.5 million shares remained outstanding under the forward sale agreements, with an initial weighted average price of $17.33 per share, net of commissions.
• Net Debt to Adjusted EBITDA was 5.27x as of December 31, 2024.
• A quarterly cash dividend of $0.30 per share of common stock was declared, payable on February 28, 2025.
• Sabra introduced 2025 earnings guidance, projecting net income between $0.67 and $0.70 per diluted common share.
• FFO is expected to be between $1.42 and $1.45, Normalized FFO between $1.43 and $1.46, AFFO between $1.47 and $1.50, and Normalized AFFO between $1.48 and $1.51 per diluted common share.
• The 2025 guidance assumes low-single-digit Cash NOI growth for the triple-net portfolio and low-to-mid teens Cash NOI growth for the same-store managed senior housing portfolio.
• General and administrative expenses are estimated at approximately $50 million, including $11 million of stock-based compensation expense.
• The weighted average share count is projected to be approximately 240 million and 241 million for Normalized FFO and Normalized AFFO, respectively.
• The guidance assumes no additional tenants are placed on a cash basis for revenue recognition and no 2025 investment, disposition, or capital markets activity.
• As of December 31, 2024, Sabra had approximately $980.0 million of liquidity.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong Q4 results and optimistic 2025 guidance. The company's strategic initiatives and financial health contribute to a favorable sentiment.

Positives

• Strong Q4 2024 performance with solid net income and FFO figures.
• Significant year-over-year growth in same-store managed senior housing Cash NOI (17.9%).
• Successful acquisitions and dispositions, enhancing portfolio quality and yield.
• Healthy balance sheet with a Net Debt to Adjusted EBITDA ratio of 5.27x.
• Consistent dividend payout of $0.30 per share.
• Optimistic 2025 earnings guidance, indicating continued growth and profitability.
• High liquidity position of approximately $980.0 million.

Negatives

• The guidance assumes no additional tenants are placed on a cash basis for revenue recognition and no 2025 investment, disposition, or capital markets activity, which could limit flexibility.
• General and administrative expenses are estimated at approximately $50 million, including $11 million of stock-based compensation expense.

Risks

• The forward-looking statements are subject to various factors that could cause actual results to differ materially, including increased labor costs, interest rate hikes, and the impact of pandemics.
• Operational risks associated with senior housing-managed communities and competitive conditions in the industry could affect performance.
• Tenants' dependency on governmental reimbursement programs and the potential for tenant bankruptcies pose risks.
• Changes in macroeconomic conditions and disruptions in financial markets could impact Sabra's ability to raise capital and service its debt.

Future Outlook

Sabra anticipates continued growth in 2025, driven by low-single-digit Cash NOI growth for the triple-net portfolio and low-to-mid teens Cash NOI growth for the same-store managed senior housing portfolio. The company expects to maintain a strong balance sheet and capitalize on investment opportunities.

Management Comments

• Rick Matros, CEO and Chair, stated, 'We are proud of our results for the year, which reflect the strategy we articulated prior to 2024 and have since executed on.'
• Rick Matros also noted, 'Our skilled nursing portfolio continues to enjoy occupancy and skilled mix gains, and EBITDARM coverage now exceeds two times.'
• Talya Nevo-Hacohen, Chief Investment Officer, commented, 'By consistently and deliberately executing our strategy, we deliver long-term value to our shareholders and provide the capital our tenants need to invest in their business and deliver quality care.'

Industry Context

Sabra's focus on skilled nursing and senior housing aligns with the growing demand driven by an aging population. The company's strategic relationships with operators and its focus on portfolio optimization position it well to capitalize on industry trends.

Comparison to Industry Standards

• Sabra's Net Debt to Adjusted EBITDA of 5.27x is within the range of investment-grade peers (3.49x 5.93x).
• Sabra's Interest Coverage Ratio of 4.40x is also within the range of its peers (3.90x 5.56x).
• Sabra's Debt as a % of Asset Value of 37% is comparable to its peers (25% 42%).
• Sabra's Secured Debt as a % of Asset Value is low at 1% compared to peers (2% 8%).
• Compared to peers like LTC Properties (LTC), Omega Healthcare Investors (OHI), National Health Investors (NHI), CareTrust REIT (CTRE), and AHR, Sabra maintains a competitive position in terms of valuation and portfolio composition.

Stakeholder Impact

• Shareholders can expect continued dividend payouts and potential for capital appreciation.
• Employees benefit from a diverse and inclusive work environment.
• Tenants receive capital support for growth and quality care initiatives.
• Residents and patients benefit from improved facilities and care quality.

Next Steps

• The company intends to continue executing its strategy, focusing on accretive investments, supporting operator expansion, and optimizing its portfolio.
• Sabra will continue to curate its portfolio to optimize diversification and maintain a mix of assets well-positioned for the future of healthcare delivery.
• The company plans to maintain balance sheet strength and lower leverage by match funding accretive investing activity with a combination of available liquidity, recycled capital and ATM proceeds.

Key Dates